Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Osteoarthritis

FDA Panel Votes on Tanezumab for Osteoarthritis Pain

Diana Ernst, RPh

April 2, 2021

Tanezumab is a humanized monoclonal antibody that selectively targets, binds to, and inhibits nerve growth factor.

General Rheumatology

Primary Analysis Shows AstraZeneca COVID-19 Vaccine 76% Effective

Diana Ernst, RPh

March 31, 2021

The primary analysis was found to be consistent with interim data that had been released earlier this week.

General Rheumatology

REGEN-COV in High-Risk, Non-Hospitalized Patients With COVID-19 Assessed

Diana Ernst, RPh

March 30, 2021

Moreover, COVID-19 symptom duration was shortened by an average of 4 days in both dose groups.

Pain Management

FDA Cracks Down on Companies Selling Unapproved CBD Products

Diana Ernst, RPh

March 29, 2021

The products described in the warning letters are being marketed as topical pain therapies, though none have actually been evaluated by the FDA.

Spondyloarthritis

Benefits of Guselkumab Observed Through 2 Years in Psoriatic Arthritis Trial

Diana Ernst, RPh

March 24, 2021

The DISCOVER-2 study aimed to evaluate multiple clinical outcomes including joint and skin symptoms and radiographic progression in patients with psoriatic arthritis.

General Rheumatology

CDC Provides Guidance for Individuals Fully Vaccinated Against COVID-19

Diana Ernst, RPh

March 23, 2021

Fully vaccinated individuals can visit with other fully vaccinated people, or unvaccinated people from a single household who are at low risk for severe COVID-19 disease, indoors without wearing masks or physical distancing.